Your browser doesn't support javascript.
loading
Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families.
Harripaul, R; Vasli, N; Mikhailov, A; Rafiq, M A; Mittal, K; Windpassinger, C; Sheikh, T I; Noor, A; Mahmood, H; Downey, S; Johnson, M; Vleuten, K; Bell, L; Ilyas, M; Khan, F S; Khan, V; Moradi, M; Ayaz, M; Naeem, F; Heidari, A; Ahmed, I; Ghadami, S; Agha, Z; Zeinali, S; Qamar, R; Mozhdehipanah, H; John, P; Mir, A; Ansar, M; French, L; Ayub, M; Vincent, J B.
Afiliación
  • Harripaul R; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Vasli N; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Mikhailov A; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Rafiq MA; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Mittal K; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Windpassinger C; Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan.
  • Sheikh TI; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Noor A; Institute of Human Genetics, Medical University of Graz, Graz, Austria.
  • Mahmood H; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Downey S; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Johnson M; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
  • Vleuten K; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Bell L; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Ilyas M; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Khan FS; Fleming College, Peterborough, ON, Canada.
  • Khan V; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Moradi M; Fleming College, Peterborough, ON, Canada.
  • Ayaz M; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Naeem F; Fleming College, Peterborough, ON, Canada.
  • Heidari A; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Ahmed I; Fleming College, Peterborough, ON, Canada.
  • Ghadami S; Human Molecular Genetics Lab, Department of Bioinformatics and Biotechnology, FBAS, International Islamic University, Islamabad, Pakistan.
  • Agha Z; Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan.
  • Zeinali S; Department of Biochemistry, Quaid-i-Azam University, Islamabad, Pakistan.
  • Qamar R; Qazvin University of Medical Science, Qazvin, Iran.
  • Mozhdehipanah H; Lahore Institute of Research & Development, Lahore, Pakistan.
  • John P; Lahore Institute of Research & Development, Lahore, Pakistan.
  • Mir A; Department of Psychiatry, Queen's University, Kingston, ON, Canada.
  • Ansar M; Molecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • French L; Division of Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada.
  • Ayub M; Atta-ur-Rehman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), Islamabad, Pakistan.
  • Vincent JB; Department of Molecular Medicine, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Mol Psychiatry ; 23(4): 973-984, 2018 04.
Article en En | MEDLINE | ID: mdl-28397838
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Consanguinidad / Discapacidad Intelectual Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Consanguinidad / Discapacidad Intelectual Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2018 Tipo del documento: Article País de afiliación: Canadá